Search

Displaying results 5791 - 5800 of 10000 in total
  1. Drug

    Pinoxepin

    go.drugbank.com/drugs/DB21397
    Experimental

    The usage of the INN stem '-oxepin' in the name indicates that Pinoxepin is a tricyclic compound. Pinoxepin has a monoisotopic molecular weight of 398.18 Da.

  2. Drug

    Ruzadolane

    go.drugbank.com/drugs/DB21444
    Experimental

    The usage of the INN stem '-adol/-adol-' in the name indicates that Ruzadolane is a analgesic. Ruzadolane has a monoisotopic molecular weight of 375.13 Da.

  3. Drug

    Alpibectir

    go.drugbank.com/drugs/DB21561
    Investigational

    Alpibectir has a monoisotopic molecular weight of 332.1 Da. … Alpibectir is under investigation in clinical trial NCT06748937 (A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide).

  4. Drug

    Hydrogenobyrinic acid

    go.drugbank.com/drugs/DB02460
    Experimental

    Categories: Heterocyclic Compounds with 4 or More Rings
  5. Drug

    Diacetyldeuteroheme

    go.drugbank.com/drugs/DB03418
    Experimental

    Categories: Heterocyclic Compounds with 4 or More Rings
  6. Drug

    Coproporphyrin I

    go.drugbank.com/drugs/DB03727
    Experimental

    Categories: Heterocyclic Compounds with 4 or More Rings
  7. Drug

    Vatalanib

    go.drugbank.com/drugs/DB04879
    Investigational

    Vatalanib is under investigation for the treatment of solid tumors.

  8. Drug

    Prenalterol

    go.drugbank.com/drugs/DB13777
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  9. Drug

    Denufosol

    go.drugbank.com/drugs/DB04983
    Investigational

    The drug was also evaluated in the treatment of retinal detachment and other diseases of the retina. Denufosol has not gained FDA approval, and clinical trials with this drug have ceased since 2011. … Denufosol was an inhaled drug used for the treatment of cystic fibrosis (CF), showing various improvements in lung function during a phase III clinical trial.

  10. Drug

    SQ-109

    go.drugbank.com/drugs/DB05186
    Investigational

    SQ-109 is an orally active, small molecule antibiotic for treatment of pulmonary TB. … Currently in Phase I clinical trials, SQ-109 could replace one or more drugs in the current first-line TB drug regimen, simplify therapy, and shorten the TB treatment regimen.

    Synonyms: N-adamantanyl-N'-geranyl-ethylenediamine